Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survivl in the TAX 327 study

DR Berthold, GR Pond, F Soban, Pirkko-Liisa Kellokumpu-Lehtinen, R de WIT, M Eisenberger, IF Tannock

Research output: Contribution to journalArticleScientificpeer-review

852 Citations (Scopus)
Original languageEnglish
Pages (from-to)242-245
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume26
Issue number2
DOIs
Publication statusPublished - 2008
Publication typeA1 Journal article-refereed

Cite this